Skip to main content
Fig. 2 | Radiation Oncology

Fig. 2

From: Diffusion-weighted MRI and 18F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma

Fig. 2

ROC curves of the combined model to predict pCR-T. AUC of TLG-Tpost: 0.828(95% CI: 0.682–0.925); AUC of ADCduring: 0.880(95%CI: 0.704–0.962); AUC of combined model 0.914(95%CI: 0.759–0.983). TLG total lesion glycolysis; ADC apparent diffusion coefficient; ROC receiver operating characteristic; AUC areas under the curve; CI confidence interval

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us